Biogen International GmbH et al v. Pharmathen S.A. > Summary
Court Case Number 1:17-cv-00855
Filing Date Jun 28, 2017
Termination Date Sep 22, 2020
Court Delaware District Court
Status Judgment - Court Trial
Appeal2021-1078
JudgesMaryellen Noreika
Defendant
Plaintiff Attorneys
12Biogen
Attorney Name: Steven J. Balick
Ashby & Geddes
Biogen
Attorney Name: Li Feng
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Biogen
Attorney Name: James B. Monroe
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen
Attorney Name: Andrew E. Renison
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen MA Inc.
Attorney Name: Steven J. Balick
Ashby & Geddes
Biogen MA Inc.
Attorney Name: Li Feng
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen MA Inc.
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Biogen MA Inc.
Attorney Name: James B. Monroe
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen MA Inc.
Attorney Name: Andrew E. Renison
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen
Attorney Name: Sanya Sukduang
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen MA Inc.
Attorney Name: Sanya Sukduang
Finnegan, Henderson, Farabow, Garrett & Dunner
Defendant Attorneys
6Pharmathen S.A.
Attorney Name: Pilar G. Kraman
Young Conaway Stargatt & Taylor
Pharmathen S.A.
Attorney Name: Adam W. Poff
Young Conaway Stargatt & Taylor
Pharmathen S.A.
Attorney Name: Cedric Cy Tan
Pillsbury Winthrop Shaw Pittman
Pharmathen S.A.
Attorney Name: Hemant Keeto Sabharwal
Pillsbury Winthrop Shaw Pittman
Attorney Name: Pilar G. Kraman
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08759393 | Utilization of dialkylfumarates | Jun 24, 2014 |
| 08399514 | Treatment for multiple sclerosis | Mar 19, 2013 |
| 07803840 | Utilization of dialkylfumarates | Sep 28, 2010 |
| 07619001 | Utilization of dialkylfumarates | Nov 17, 2009 |
| 07320999 | Dimethyl fumarate for the treatment of multiple sclerosis | Jan 22, 2008 |
| 06509376 | Utilization of dialkyfumarates | Jan 21, 2003 |
